Furthermore, in vivo blockade of IL-21 ameliorated disease progression and severity in some of these settings (126–128), as well as in animal models of rheumatoid arthritis (129) and Sjogren’s syndrome (130). Here, IL21 is linked to Sjogren syndrome.